Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.
USD 29.95
Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.

Contact Information

Legal Address
"Ajanta House",, Charkop, Kandivli (West)
Mumbai; Maharashtra; Map
Postal Code: 400067
Tel: 6606
Fax: 6606
Email: @ajantapharma.com
Website: http://www.ajantapharma.com

Full name: Ajanta Pharma Ltd.

Status: Listed
Legal Form: Public Limited Company
Operational Status: Operational
EMISid: 1620284
IN-CIN: L24230MH1979PLC022059
ISIN: INE031B01049
Incorporation Date: 1973

Main Activities

Main Activities: Pharmaceutical and Medicine Manufacturing

Main Products

Capsules, Liquids, Powder, Injectibles, Ointments, Tablets, Bulk Drugs (Intermediates),
More

Company Description

Ajanta Pharma Ltd. is a pharmaceutical company engaged in development, manufacture and marketing of finished dosages. Established in 1973, the company has therapeutic segments of Cardiovascular, dermatology, ophthalmology and musculoskeletal. Ajanta Pharma Ltd.'s office is based in Mumbai.

More

Basic Information

Total Employees:
()
Outstanding Shares:
: ()
Registered Capital:
()
Financial Auditors:
()

EMIS Benchmark Score

View all parameters in Benchmark Score

Quote Chart

Quote Summary

Last Price 1,713.90
Volume 11,152
Turnover 19,240,546
Index    S&P CNX 500
Market Bombay Stock Exchange
Ticker 532331
Market Cap Market Cap 150,831,770
52 Week High 2,088.55
52 Week Low 1,289.05
Price to Earnings (P/E) 37.58
Earnings per Share (EPS) 45.61
Dividend Yield 6.25 (March 31, 2013)
Bookvalue 11,497,700
Enterprise Value 118,182,415
Quote updated on February 22, 2017
Note: data in INR Thousands.

Export-Import

2014: Imports INR 374,075.00 Thousands
Import connections ('000)
Total(5,906.62)
2014: Exports INR 3,426,839.00 Thousands
Export connections ('000)
Total(54,109.55)

Key Executives

Chairman
More

Ownership Details

Indian Promoters
73.78%
More

Key Stats

Select Items to chart them. 2017 Q3C
Net sales revenue
Total operating revenue
Operating profit (EBIT)
EBITDA
Net Profit (Loss) for the Period
Total assets N/A
Total equity
Operating Profit (EBIT) Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to Equity
Quick Ratio
Cash Ratio
Note: units in Thousands. Statement: Non-Audited, Consolidated
Source: Dion Global Solutions Limited, EMIS Company Database.

Financials

Competitors - India

INR | USD | EUR

EMIS DealWatch Deals

DealMonitor Deal Intents

for 29.95 USD
Payment methods include:
USD 29.95
Most recent financial data: 2016
Payment methods include:
The full PDF report for this company will be available to download immediately after purchase. The report will contain:
Company Tear Sheet
Contact Information
NAICS Industry Classification
Business description
Basic Information
Share Price information
Key Executives
Ownership Details
Subsidiaries and Affiliates
Key Financial Highlights
Financial Performance Charts
Latest M&A and ECM Deals
Top Competitors
Financial Statements
Annual Statements
Ratios
EMIS Credit Analytics
EMIS Benchmark Score

- or -

EMIS company profiles are part of a larger information service that combines company, industry and country data and analysis for over 120 emerging markets on a unique information platform.

If you need broad and deep coverage of one or many countries, you may be interested in subscribing. Request a demonstration of our full service and one of our account managers will be in touch.

Register Your Interest